DrugDashboards

Allergy Multi Symptom

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE · ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1 · Tablet, Coated · Oral · Chain Drug Marketing Association, Inc.

NDC 83324-0086-24 · 2 BLISTER PACK in 1 CARTON / 12 TABLET, COATED in 1 BLISTER PACK · OTC MONOGRAPH DRUG · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0882 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Dec 2024Sep 2026$0.0882
22 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$2.64
#90 count
$7.93

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for acetaminophen, chlorpheniramine maleate, phenylephrine hydrochloride (oral solid) in the next 90 days

sole-source market · price up 5% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
M012
TE code
Approval date
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, and PHENYLEPHRINE HYDROCHLORIDE (Tablet, Coated)

LabelerStrengthFirst seenLast seen
Aaa Pharmaceutical, Inc.PHENYLEPHRINE HYDROCHLORIDE 5 mg/1; ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1Aug 26, 2026Sep 2, 2026
Amerisource BergenACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Chain Drug Marketing Association IncACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Chain Drug Marketing Association, Inc.ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Discount Drug MartACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
GoodsenseACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
HebACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Marc Glassman, Inc.CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1; ACETAMINOPHEN 325 mg/1Aug 26, 2026Sep 2, 2026
Retail Business Services , Llc.ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Strategic Sourcing Services LlcACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Topco Associates LlcACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Aaa Pharmaceutical, Inc.PHENYLEPHRINE HYDROCHLORIDE 325 mg/1; ACETAMINOPHEN 2 mg/1; CHLORPHENIRAMINE MALEATE 5 mg/1Jul 22, 2026Aug 19, 2026
Marc Glassman, Inc.CHLORPHENIRAMINE MALEATE 325 mg/1; PHENYLEPHRINE HYDROCHLORIDE 2 mg/1; ACETAMINOPHEN 5 mg/1Jul 22, 2026Aug 19, 2026
Aaa Pharmaceutical, Inc.ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 15, 2026
Marc Glassman, Inc.ACETAMINOPHEN 325 mg/1; CHLORPHENIRAMINE MALEATE 2 mg/1; PHENYLEPHRINE HYDROCHLORIDE 5 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Allergy Multi Symptom — NDC 83324-0086-24," retrieved September 3, 2026, https://drugdashboards.com/drug/83324008624.

Free to cite with attribution — see how the data is put together.